Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation [Phase 1]
This is a Phase 1 trial update announcing ongoing recruitment for a study evaluating TSC-100 and TSC-101 in patients with acute myeloid leuk…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study [Phase 1, Phase 2]
PedAL BCU, LLC is conducting a pediatric screening trial to test bone marrow and blood methods in children with relapsed or hard-to-treat ac…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Backtracking Leukemia-Typical Somatic Mutations in Cord Blood
A clinical trial is actively recruiting to study leukemia-associated somatic mutations in cord blood for acute lymphoblastic leukemia and ac…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents [Phase 2]
Phase 2 clinical trial update evaluating the triple combination of Tagraxofusp, Azacitidine, and Venetoclax in newly diagnosed secondary acu…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML [Phase 2]
Phase 2 study evaluating induction therapy with azacitidine and venetoclax followed by venetoclax maintenance in elderly patients with acute…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia [Phase 2]
This is a Phase 2 clinical trial evaluating venetoclax plus azacitidine in combination with chidamide and the CAG regimen for fit, older pat…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: VA-CIG Regimen for Previously Untreated Acute Myeloid Leukemia: A Multicenter Prospective Single-Arm Trial [Phase 2]
A Phase 2 multicenter prospective single-arm trial evaluating the VA-CIG regimen as first-line treatment for previously untreated acute myel…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology [NA]
A completed clinical trial examined whether a high-fiber, low-fat diet can prevent recurrent Clostridioides difficile infection in oncology …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A clinical trial is enrolling people with and without cancer to collect blood samples and evaluate tests for early cancer detection across m…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies [Phase 1]
Phase 1 safety trial update for SEA-CD70 in myeloid malignancies; the study in myelodysplastic syndrome and acute myeloid leukemia is curren…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT [Phase 1]
Phase 1 clinical trial update on DLI-X as a prophylactic and therapeutic donor lymphocyte infusion to prevent or treat leukemia relapse afte…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML) [Phase 3]
This Phase 3 clinical trial assesses bleximenib in combination with standard induction/consolidation therapy followed by maintenance for adu…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating venetoclax in combination with a CACAG regimen versus the 3+7 regimen for acute monocytic leukemia is cu…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing Treatment
An exploratory UK clinical trial sponsored by the University of Oxford is evaluating wearable technology to collect health data in people wi…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study [NA]
Completed clinical trial evaluating a geriatric optimization plan to improve survival in older adults undergoing allogeneic hematopoietic ce…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy [NA]
This ClinicalTrials.gov entry describes a collaborative palliative and leukemia care model for patients with AML or myelodysplastic syndrome…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies [Phase 2]
Phase 2 clinical trial evaluating MT2021-08T, a T-cell receptor alpha/beta-depleted donor peripheral blood stem cell product, for hematologi…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML [Phase 1]
Phase 1 trial exploring axatilimab with decitabine and venetoclax for TP53-mutated acute myeloid leukemia; the study status is not yet recru…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 1]
A Phase 1 study of Gentulizumab in relapsed/refractory acute myeloid leukemia or myelodysplastic syndromes has been terminated.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Leukemia Adapted Protocol
This is an update on an ongoing clinical trial (NCT06928909) at Baylor College of Medicine evaluating an adapted protocol for acute myeloid …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) [Phase 2, Phase 3]
The AZTOUND study is evaluating ASTX030 (azacitidine and cedazuridine) alone or in combination with venetoclax in myeloid neoplasms includin…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating CTX131 in adults with relapsed or refractory hematologic malignancies, assessing safety and efficacy …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation [Phase 1]
Phase 1 trial evaluating CIML NK cell infusion for relapse of myeloid disease after hematopoietic cell transplantation; the study is current…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML [Phase 1]
A Phase 1 clinical trial is testing an adoptive T cell therapy combined with a DC/AML fusion vaccine plus decitabine and venetoclax in acute…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Telehealth Advance Care Planning Intervention [NA]
An ongoing clinical trial at the University of Rochester is evaluating a telehealth advance care planning intervention for myeloid malignanc…